Cordyceps Sunshine Biotech Holdings (RAJAF) Retained Earnings (2020 - 2025)

Cordyceps Sunshine Biotech Holdings' Retained Earnings history runs 6 years deep, the most recent figure standing at $87095.0 for Q4 2025.

• In Q4 2025, Retained Earnings fell 4.59% year-over-year to $87095.0; the TTM figure through Dec 2025 stood at $87095.0 (down 4.59% YoY), while the FY2025 annual figure was $87095.0, down 4.59% from the prior year.
• Retained Earnings was $87095.0 for Q4 2025 at Cordyceps Sunshine Biotech Holdings, down from $91281.0 in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $91281.0 in Q4 2024 to a low of -$477490.0 in Q3 2023.
• Historically, Retained Earnings has averaged -$28872.3 across 5 years, with a median of $63968.0 in 2022.
• The sharpest annual moves came in 2021 and 2022: Retained Earnings plunged 661.9% in 2021, then soared 1194.64% in 2022.
• A 5-year view of Retained Earnings shows it stood at -$3731.0 in 2021, then jumped by 1194.64% to $40841.0 in 2022, then soared by 117.36% to $88770.0 in 2023, then grew by 2.83% to $91281.0 in 2024, then decreased by 4.59% to $87095.0 in 2025.
• The last three Retained Earnings figures came in at $87095.0 (Q4 2025), $91281.0 (Q4 2024), and $88770.0 (Q4 2023), per Business Quant data.